143 related articles for article (PubMed ID: 28894229)
21. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Pieraccioli M; Nicolai S; Pitolli C; Agostini M; Antonov A; Malewicz M; Knight RA; Raschellà G; Melino G
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7356-7361. PubMed ID: 29941555
[TBL] [Abstract][Full Text] [Related]
22. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
23. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor in children with neuroblastoma: a retrospective analysis.
Jakovljević G; Culić S; Stepan J; Bonevski A; Seiwerth S
J Exp Clin Cancer Res; 2009 Nov; 28(1):143. PubMed ID: 19895696
[TBL] [Abstract][Full Text] [Related]
25. Flavopiridol inhibits vascular endothelial growth factor production induced by hypoxia or picolinic acid in human neuroblastoma.
Rapella A; Negrioli A; Melillo G; Pastorino S; Varesio L; Bosco MC
Int J Cancer; 2002 Jun; 99(5):658-64. PubMed ID: 12115498
[TBL] [Abstract][Full Text] [Related]
26. Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization.
Fukuzawa M; Sugiura H; Koshinaga T; Ikeda T; Hagiwara N; Sawada T
J Pediatr Surg; 2002 Dec; 37(12):1747-50. PubMed ID: 12483647
[TBL] [Abstract][Full Text] [Related]
27. CFC1 is a cancer stemness-regulating factor in neuroblastoma.
Chikaraishi K; Takenobu H; Sugino RP; Mukae K; Akter J; Haruta M; Kurosumi M; Endo TA; Koseki H; Shimojo N; Ohira M; Kamijo T
Oncotarget; 2017 Jul; 8(28):45046-45059. PubMed ID: 28620148
[TBL] [Abstract][Full Text] [Related]
28. Lymphangiogenesis and its regulation in human neuroblastoma.
Lagodny J; Jüttner E; Kayser G; Niemeyer CM; Rössler J
Biochem Biophys Res Commun; 2007 Jan; 352(2):571-7. PubMed ID: 17140547
[TBL] [Abstract][Full Text] [Related]
29. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor expression is closely related to irinotecan-mediated inhibition of tumor growth and angiogenesis in neuroblastoma xenografts.
Kaneko S; Ishibashi M; Kaneko M
Cancer Sci; 2008 Jun; 99(6):1209-17. PubMed ID: 18384433
[TBL] [Abstract][Full Text] [Related]
31. DUSP5 expression associates with poor prognosis in human neuroblastoma.
Aurtenetxe O; Zaldumbide L; Erramuzpe A; López R; López JI; Cortés JM; Pulido R; Nunes-Xavier CE
Exp Mol Pathol; 2018 Dec; 105(3):272-278. PubMed ID: 30171833
[TBL] [Abstract][Full Text] [Related]
32. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.
Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H
Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475
[TBL] [Abstract][Full Text] [Related]
33. The lymphangiogenesis inhibitor esVEGFR-2 in human embryos: expression in sympatho-adrenal tissues and differentiation-induced up-regulation in neuroblastoma.
Becker J; Fröhlich J; Hansen J; Zelent C; Perske C; Wilting J
Histol Histopathol; 2012 Jun; 27(6):721-33. PubMed ID: 22473693
[TBL] [Abstract][Full Text] [Related]
34. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
35. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.
Chang HH; Chen CH; Chou CH; Liao YF; Huang MJ; Chen YH; Wang WJ; Huang J; Hung JS; Ho WL; Jeng YM; Che MI; Lee H; Lu MY; Yang YL; Jou ST; Lin DT; Lin KH; Hsu WM; Huang MC
Clin Cancer Res; 2013 Apr; 19(7):1705-16. PubMed ID: 23444218
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
[TBL] [Abstract][Full Text] [Related]
37. HIF-1α contributes to proliferation and invasiveness of neuroblastoma cells via SHH signaling.
Chen S; Zhang M; Xing L; Wang Y; Xiao Y; Wu Y
PLoS One; 2015; 10(3):e0121115. PubMed ID: 25811359
[TBL] [Abstract][Full Text] [Related]
38. High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts.
Joseph JM; Bouquet C; Opolon P; Morizet J; Aubert G; Rössler J; Gross N; Griscelli F; Perricaudet M; Vassal G
Cancer Gene Ther; 2003 Nov; 10(11):859-66. PubMed ID: 14605672
[TBL] [Abstract][Full Text] [Related]
39. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors.
Zhang J; Jia Z; Li Q; Wang L; Rashid A; Zhu Z; Evans DB; Vauthey JN; Xie K; Yao JC
Cancer; 2007 Apr; 109(8):1478-86. PubMed ID: 17340592
[TBL] [Abstract][Full Text] [Related]
40. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.
Ramraj SK; Aravindan S; Somasundaram DB; Herman TS; Natarajan M; Aravindan N
Oncotarget; 2016 Apr; 7(14):18605-19. PubMed ID: 26921195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
